EDOC:AU:AU-BetaShares Digital Health and Telemedicine ETF (AUD)

ETF | Others |

Last Closing

USD 9

Change

-0.01 (-0.11)%

Market Cap

N/A

Volume

437.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+1.54 (+1.59%)

USD 15.34B
VGS:AU Vanguard MSCI International Sh..

+0.94 (+0.77%)

USD 7.71B
IVV:AU iShares Core S&P 500 AUD

+0.37 (+0.70%)

USD 7.58B
IOZ:AU Ishares Core S&P/Asx 200

+0.51 (+1.63%)

USD 5.50B
QUAL:AU VanEck Vectors MSCI World ex A..

+0.79 (+1.46%)

USD 5.47B
STW:AU SPDR® S&P/ASX 200 Fund

+1.23 (+1.75%)

USD 5.07B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.65 (+1.71%)

USD 4.86B
A200:AU BetaShares Australia 200

+2.10 (+1.62%)

USD 4.72B
NDQ:AU Betashares Nasdaq 100

+0.48 (+1.15%)

USD 4.37B
VTS:AU Vanguard US Total Market Share..

+2.35 (+0.60%)

USD 3.95B

ETFs Containing EDOC:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.44% 6% D- 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.44% 6% D- 42% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike